References
- MoncrieffJ: An investigation into the precedents of modern drug treatment in psychiatry. History of Psychiatry 1999; 10:475–490
- Delay J, Deniker P. Harl JM: Utilisation en thérapeutique psychi-atrique d'une phénothiazine d'action centrale elective (4560 RP). Ann Méd Psychol 1952; 110:112–117
- Sen G, Bose KC: Rauwolfia serpentina: A new Indian drug for insanity and high blood pressure. Indian Medical World 1931; 11:194–201
- Kline NS: Use of Rauwolfia Serpentina Benth. In neuropsychiat-ric conditions. Ann 1VY Acad Sci 1954; 59:107–132
- Deniker P: From chlorpromazine to tardive dyskinesia (brief his-tory of the neuroleptics). Psychiatr J Univ Ott 1989; 14:253–259
- Andermann AAJ: Physicians, fads, and pharmaceuticals: A his-tory of aspirin. McGill Journal of Medicine 1996; 2:115–120
- Schwartz RS: Paul Ehrlich's magic bullets. New England Journal Medicine 2004; 350:1079–1080
- Laborit H, Huguenard P. Alluaume R: Un nouveau stabilisateur végétatif (le 4560 RP). Presse Méd 1952; 60:206–208
- Linford Rees W (in conversation with D Healy): The place of clinical trials in the development of psychopharmacology. History of Psychiatry 1997; 8:001–020
- Carlsson A: A half-century of neurotransmitter research: Impact on neurology and psychiatry. Bioscience Reports 2001; 21:691–710
- Pletscher A: The discovery of antidepressants: A winding path. Experientia 1991; 47:4–8
- Hirschfeld RM: History and evolution of the monoamine hypoth-esis of depression. J Clin Psychiatry 2000; 61:4–6
- Griesinger W: Die Pathologie und Therapie der Psychischen Krankheiten. Stuttgart: Krabbe, 1845
- Kirkby KC: After the gold rush: The expansion of asylums in country Victoria in the 1860s. Occas Pap Med Hist Aust 1999; 9
- Shepherd M: Neurolepsis and the psychopharmacological revolu-tion: Myth and reality. History of Psychiatry 1994; 5:089–096
- Bennett D: The drive towards the community. In: Berrios GE, Freeman H, eds. 150 years of British Psychiatry, 1841–1991. city? Gaskell Press, 1991:321–332
- Odegaard O: Pattern of discharge from Norwegian psychiatric hospitals before and after the introduction of the psychotropic drugs. American Journal of Psychiatry 1964; 120:772–778
- Dax EC: Asylum to community: The development of the mental hygiene service in Victoria, Australia. Melbourne: F. W. Cheshire, for the World Federation for Mental Health, 1961
- Herman DB, Susser ES, Jandorf L, Lavelle J, Bromet EJ: Home-lessness among individuals with psychotic disorders hospitalized for the first time: Findings from the Suffolk County Mental Health Project. Am J Psychiatry 1998; 155:109–113
- Fazel S, Danesh J: Serious mental disorder in 23000 prisoners: A systematic review of 62 surveys. Lancet 2002; 359:545–50
- Murray CJ, Lopez AD (Eds): Global Burden of Disease. A compre-hensive assessment of mortality and disability from diseases, inju-ries, and risk factors in 1990 and projected to 2020. World Health Organisation: Harvard University Press, 1996
- Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV: Preva-lence of and risk factors for medication nonadherence in patients with schizophrenia: A comprehensive review of recent literature. J Clin Psychiatry. 2002; 63:892–909
- Andrews G, Sanderson K, Corry J, Issakidis C, Lapsley H: Cost-effectiveness of current and optimal treatment for schizophrenia. Br J Psychiatry 2003; 183:427–435
- McIntyre R, Katzman M: The role of atypical antipsychotics in bipolar depression and anxiety disorders. Bipolar Disord 2003; 5 Suppl 2:20–35
- Carson WH, Kitagawa H: Drug development for anxiety disor-ders: new roles for atypical antipsychotics. Psychopharmacol Bull 2004; 38:38–45
- McGorry PD, Yung AR, Phillips LJ, Yuen HP, Francey S, Cosgrave EM, Germano D, Bravin J, McDonald T, Blair A, Adlard S, Jackson H: Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psycho-sis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry 2002; 59:921–928
- Killian JG, Kerr K, Lawrence C, Celermajer DS: Myocarditis and cardiomyopathyassociated with clozapine. Lancet 1999; 354 :1841–1845
- Tarsy D: History and definition of tardive dyskinesia. Clinical Neuropharmacology 1983; 6:91–99
- Lyon ER: A review of the effects of nicotine on schizophrenia and antipsychotic medications. Psychiatr Serv 1999; 50:1346–1350
- Hartwell CE: The schizophrenogenic mother concept in American psychiatry. Psychiatry 1996; 59:274–297
- Laing RD: The Divided Self: An Existential Study in Sanity and Madness. City: Penguin, 1976
- Szasz T: The origin of psychiatry: The alienist as nanny for trou-blesome adults. History of Psychiatry 1995; 6:001–019
- Scull A: Psychiatry and social control in the nineteenth and twen-tieth centuries. Hist Psychiatry 1991; 2:149–169
- The tightening grip of big pharma (editorial): Lancet 2001; 35:1141
- Nye RA: The evolution of the concept of medicalization in the late twentieth century. Journal of History of the Behavioral Sciences 2003; 39:115–129
- Eisenberg L: Mindlessness and brainlessness in psychiatry. Br J Psychiatry 1986; 148:497–508
- Tourney G: A history of therapeutic fashions in psychiatry, 1800-1966. Am J Psychiatry 1967; 124:784–96